Frank Loganzo Selected Research

Frank Loganzo Research Topics

23	Neoplasms (Cancer) 01/2022 - 04/2003
4	Breast Neoplasms (Breast Cancer) 10/2020 - 10/2004
2	Carcinoma (Carcinomatosis) 11/2004 - 04/2003
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021
1	Leukemia 01/2021
1	Lung Neoplasms (Lung Cancer) 10/2020
1	Stomach Neoplasms (Stomach Cancer) 01/2017
1	Communicable Diseases (Infectious Diseases) 07/2016
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2004
1	Necrosis 03/2004

10	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 04/2015
6	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 02/2006 - 04/2003
6	HTI-286IBA 05/2005 - 04/2003
4	auristatinIBA 01/2022 - 12/2014
4	Paclitaxel (Taxol)FDA LinkGeneric 02/2006 - 04/2003
3	Cytotoxins (Cytolysins)IBA 11/2021 - 11/2014
3	AntigensIBA 01/2021 - 04/2015
3	Ado-Trastuzumab EmtansineIBA 10/2020 - 01/2017
2	Cysteine (L-Cysteine)FDA Link 10/2020 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 04/2015 - 10/2004
2	hemiasterlinIBA 05/2005 - 11/2004
2	Docetaxel (Taxotere)FDA Link 03/2004 - 09/2003
2	Taxoids (Taxanes)IBA 03/2004 - 09/2003
2	MAC321IBA 03/2004 - 09/2003
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Fibronectins (Fibronectin)IBA 01/2022
1	Histones (Histone)IBA 01/2022
1	Extracellular Matrix ProteinsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 11/2021
1	RNA Splicing FactorsIBA 11/2021
1	RNA Precursors (Precursor, mRNA)IBA 11/2021
1	Brentuximab VedotinIBA 01/2017
1	Immune Checkpoint InhibitorsIBA 02/2016
1	Trastuzumab (Herceptin)FDA Link 04/2015
1	Peptides (Polypeptides)IBA 12/2014
1	CL 347099IBA 02/2006
1	TubulinIBA 11/2004
1	multidrug resistance-associated protein 1IBA 10/2004
1	HTI 042IBA 09/2004
1	Contrast MediaIBA 03/2004
1	Vinorelbine (Navelbine)FDA LinkGeneric 03/2004
1	Vincristine (Oncovin)FDA LinkGeneric 04/2003

9	Therapeutics 01/2022 - 11/2004
2	Drug Therapy (Chemotherapy) 08/2014 - 12/2005